Photo of a person's hands wearing blue laboratory gloves and pouring a liquid reagent into another bottle. The branded green top of the HemosIL Reagent box can be seen in the background.
Image shows the Werfen HemosIL reagents along with an ACL TOP 570 analyzer with the logos for ACL TOP Family 70 Series and HemosIL.

Comprehensive reagent menu. Total confidence.

HemosIL offers the most liquid, ready-to-use routine and specialty reagents,1-3 to streamline workflow and enhance patient care.
An illustration for HemosIL liquid, ready-to-use reagents showing that approximately 78% fewer vials are needed than competitors when using HemosIL liquid, ready-to-use reagents (4).

Ready when you are

HemosIL liquid, ready-to-use reagents reduce prep time and use up to 78% fewer vials than competitor solutions.And, with better consistency and faster reconstitution—including ReadiPlasTin, the only FDA-cleared liquid PT reagent.
Image shows HemosIL D-Dimer HS 500 vials with the text next to it that says, confidence in VTE exclusion. Light blue rings are artistically placed in the background.

Confidence in VTE exclusion

HemosIL D-Dimer HS 500: the only reagent5-7 with 100% negative predictive value for deep venous thrombosis/pulmonary emobolism exclusion, potentially saving costs in venous thromboembolism (VTE) evaluations.8
Photo shows blue-topped sample tubes in an analyzer with text beside it that says HIT results. Light green rings are artistically placed behind the photo.

HIT results in 13 minutes9

Improve your response to patients with suspected Heparin-Induced Thrombocytopenia (HIT) with a fully automated, on-demand HIT assay, delivering results in 13 minutes.9
Photo shows the boxes for HemosIL Rivaroxaban Controls and Calibrators. There are two reagent vials set in front of the boxes. Illustrative, light blue rings are artistically placed behind the boxes.

One reagent.
Four anticoagulants.

Liquid Anti-Xa: The only FDA-cleared reagent for unfractionated heparin, low molecular weight heparin, apixaban, and rivaroxaban. Ready to go, with speed and reliability when you need it most, for patients experiencing, or at risk for, a bleeding episode.

The Werfen logo is a trademark of Werfen. HemosIL, ACL, ACL TOP, ACL Elite, ACL AcuStar, ReadiPlasTin, RecombiPlasTin, SynthASil, SynthAFax are trademarks of Instrumentation Laboratory Company, d.b.a Werfen, and/or one of its subsidiaries or parent companies and may be registered in the United States Patent and Trademark Office and in other jurisdictions. All other product names, company names, marks, logos, and symbols are trademarks of their respective owners.

  1. Siemens Healthineers. Hemostasis Reagents Portfolio Brochure. USA. 2024.
  2. Diagnostica Stago. Company Catalogue. France. 2024.
  3. Werfen. Hemostasis Catalogue. USA. 2024.
  4. Werfen. Complete Hemostasis Solution Value Analysis. USA. 2025.
  5. Werfen. HemosIL D-Dimer HS Instructions for Use. 2025.
  6. Diagnostica Stago. Liatest D-Di Instructions for Use. 2025.
  7. Siemens Healthineers. INNOVANCE D-Dimer Application Sheet. 2024.
  8. Legani C, Cini M, Scarvelis D, et al. Multicenter evaluation of a new quantitative highly selective D-Dimer assay, the HemosIL D-Dimer HS 500, in patients with clinically suspected venous thromboembolism. Thromb Res. 2010;125(5):398-401. doi:10.1016/j.thromres.2009.07.013
  9. Data on file; based on software run time from idle state to completion, actual run time may vary based on instrument.

TOP70 MS4 WW REV00 9.25